Daily Archives: October 21, 2014

TWi Biotechnology Receives Orphan Drug Designation for its Lead Drug Candidate AC-201 in United States

TAIPEI, October 21, 2014 /PRNewswire/ — TWi Pharmaceuticals, Inc. today announced that its fully owned subsidiary, TWi Biotechnology, Inc., has received the designation of Orphan Drug by US FDA for…

WuXi PharmaTech Schedules Third-Quarter 2014 Earnings Release

SHANGHAI, October 21, 2014 /PRNewswire/ — WuXi PharmaTech (Cayman) Inc. (NYSE: WX), a leading open-access R&D capability and technology platform company serving the pharmaceutical, biotechnology and medical device industries, with…

Sinovac to Participate in Jefferies 4th Annual Asia Summit

BEIJING, October 21, 2014 /PRNewswire/ — Sinovac Biotech Ltd. (NASDAQ: SVA), a leading provider of biopharmaceutical products in China, today announced that the Company’s management will host investor meetings at…

Marken Expands Cold Chain Capacity To Meet Growing Demand

RESEARCH TRIANGLE PARK, N.C., Oct. 21, 2014 /PRNewswire/ — Marken confirmed today that their global cold chain network will be expanded to respond to the growing need for just in time…

Maxwell Biotech Portfolio Company Hepatera Announces Proof-of-Concept Clinical Results with Myrcludex B, a Novel Entry Inhibitor for Treatment of Chronic Hepatitis B and Delta

MOSCOW, Oct. 21, 2014 /PRNewswire/ — Hepatera Ltd and its development partner MYR GmbH announced today the results of clinical trials investigating Myrcludex B in patients with chronic hepatitis B…

Mediso Extends the Preclinical Portfolio by 3T and 7T MRI, Via a New Strategic Collaboration

GOTHENBURG, Sweden, Oct. 21, 2014 /PRNewswire/ — Mediso Ltd announced today at the annual congress of the European Association of Nuclear Medicine the launch of new MRI subsystems with 3…